ADA Guidelines on Lipid Management in Those with Diabetes
Atherosclerotic cardiovascular disease (ASCVD)–defined as coronary heart disease (CHD), cerebrovascular disease, or peripheral arterial disease presumed to be of atherosclerotic origin – is the leading cause of morbidity and mortality for individuals with diabetes and results in an estimated $37.3 billion in cardiovascular-related spending per year associated with diabetes. Common conditions coexisting with type 2 diabetes (eg, hypertension and dyslipidaemia) are clear risk factors for ASCVD, and diabetes itself confers independent risk. This is a shortened version of the American Diabetes Association (ADA)’s article on cardiovascular risk management in Standards of Medical Care in Diabetes–2022
Modern Medicine – Issue 6 2022
